Charles River Laboratories International, Inc. Common Stock (NY:CRL)

290.19 +3.36 (+1.17%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Why Charles River Laboratories Stock Is Jumping Today ↗

November 02, 2022

Investors liked the company's Q3 update.

Via The Motley Fool

Charles River: Q3 Earnings Insights ↗

November 02, 2022

Charles River (NYSE:CRL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Charles River beat estimated...

Via Benzinga

Charles River Laboratories Announces Third-Quarter 2022 Results

November 02, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

Expert Ratings for Charles River ↗

September 30, 2022

Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:

Via Benzinga

5 Analysts Have This to Say About Charles River ↗

September 30, 2022

Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:

Via Benzinga

Where Charles River Stands With Analysts ↗

September 30, 2022

Charles River (NYSE:CRL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership

October 18, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call

October 11, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs

October 10, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Expert Ratings for Charles River ↗

August 25, 2022

Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:

Via Benzinga

Recap: Charles River Q2 Earnings ↗

August 03, 2022

Charles River (NYSE:CRL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗

September 30, 2022

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 ↗

September 30, 2022

Upgrades

Via Benzinga

'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company ↗

September 30, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock.

Via Benzinga

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 08, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration

September 06, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Charles River Laboratories Expands Contract Vivarium Space on West Coast

August 23, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗

August 16, 2022

Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.

Via Benzinga

Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product

August 09, 2022

From Charles River Laboratories, International Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022 ↗

August 04, 2022

Upgrades

Via Benzinga

AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday ↗

August 03, 2022

Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.

Via Benzinga

Charles River Laboratories Announces Second-Quarter 2022 Results

August 03, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

'I'm Going To Have To Say Avoid It': Jim Cramer Urges Waiting Before Buying This Tech Stock ↗

August 02, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Charles River Laboratories International Inc (NYSE: CRL).

Via Benzinga

Where Charles River Stands With Analysts ↗

July 14, 2022

Over the past 3 months, 5 analysts have published their opinion on Charles River (NYSE:CRL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call

July 11, 2022

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.